Bio-Process Systems Alliance Appoints Freudenberg Medical’s Jayanthi Grebin to Board of Directors
Jayanthi Grebin, Business Development Manager, Pharmaceuticals at Freudenberg Medical, was appointed to the Board of the Bio-Process Systems Alliance (BPSA), the international association of the single-use bioprocessing industry, for the 2024-2025 term. She joins colleagues from Sanofi, Millipore Sigma, Meissner, and Thermo Fisher Scientific in order to help educate and accelerate the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines.
Ms. Grebin has been a part of BPSA for 10 years. She authored a paper on particulate concerns in single-use biomanufacturing and has chaired a working group for viral vector manufacturing using single-use within the cell and gene therapy market. "I have been a big advocate of BPSA for many years and I am pleased for the opportunity to join their board," said Jayanthi Grebin. "The organization helped me with published resources when I was a product manager launching a new single-use product in this market. Now I am proud to serve as a BPSA board member to help educate, lead, and guide members to advocate for the use of single-use products in biomanufacturing."
Learn more about BPSA and Freudenberg Medical's single-use products for critical fluid transfer and bioprocessing.